levodopa has been researched along with ANS (Autonomic Nervous System) Diseases in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (15.87) | 18.7374 |
1990's | 20 (31.75) | 18.2507 |
2000's | 18 (28.57) | 29.6817 |
2010's | 13 (20.63) | 24.3611 |
2020's | 2 (3.17) | 2.80 |
Authors | Studies |
---|---|
Comoglu, S; Dinc, E; Kocer, B; Onder, H; Poyraz, U | 1 |
Pilipovich, AA; Vorob'eva, OV | 1 |
Dutkiewicz, J; Friedman, A; Szlufik, S | 1 |
Bohnen, NI; Chou, KL; Gilman, S | 1 |
Dong, Q; Fang, L; Li, J; Liao, J; Lu, T; Lu, Z; Peng, F; Qin, F; Qiu, W; Sun, X; Xu, X | 1 |
Arakawa, M; Hokari, M; Ishikawa, A; Kondo, T; Mezaki, N; Miura, T; Nishizawa, M; Ozawa, T; Sakai, N; Takeshima, A; Takeuchi, R; Tokunaga, J; Utsumi, K; Yokoseki, A | 1 |
Benarroch, EE; Calandra, CR; Cersosimo, MG; Gutiérrez, C; Micheli, FE; Pellene, A; Raina, GB | 1 |
Doi, H; Hirai, S; Kishi, M; Sakakibara, R; Tateno, F; Tsuyuzaki, Y | 1 |
Babuśka-Roczniak, M; Brodziak-Dopierała, B; Cipora, E; Kwapuliński, J; Nowak, P; Oświęcimska, JM; Roczniak, W; Widuchowski, W | 1 |
Barros, IS; Brito, BS; de Araújo, DF; de Araújo, IT; de Melo Neto, AP; Gondim, Fde A; Horta, WG; Lima, JW; Oliveira, ÍS | 1 |
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D | 1 |
Compta, Y; Ezquerra, M; Martí, MJ; Rey, MJ | 1 |
Berrocal-Izquierdo, N; Castrillo-Sanz, A; Martínez-Pueyo, A; Rodríguez-Vico, JS | 1 |
Ivanov, AK; Levin, OS; Smolentseva, IG | 1 |
Budzianowska, A; Gołab-Janowska, M; Honczarenko, K | 1 |
Chouinard, S; Gagnon, JF; Latreille, V; Montplaisir, J; Panniset, M; Postuma, RB; Romenets, SR | 1 |
Barker, RA; Brooks, DJ; Burn, DJ; Coleman, S; Duncan, GW; Khoo, TK; O'Brien, JT; Yarnall, AJ | 1 |
Bhatia, KP; Critchley, P; Graham, E; Khan, NL; Lees, AJ; Quinn, N; Schrag, AE; Wood, NW | 1 |
Eldadah, B; Goldstein, DS; Holmes, C; Pechnik, S; Sharabi, Y | 1 |
Bordet, R; Destee, A; Devos, D; Guieu, JD; Kroumova, M; Libersa, C; Vodougnon, H | 1 |
Nakatsuka, A; Nomoto, M | 1 |
Hirato, M; Kita, K; Kondo, T; Okamoto, K; Yuasa, T | 1 |
Bouhaddi, M; Cappelle, S; Fortrat, JO; Henriet, MT; Regnard, J; Rumbach, L; Vuillier, F | 1 |
Corneliusson, O; Elam, M; Holmberg, B | 1 |
Le Rhun, E; Lebert, F | 1 |
Aniel-Quiroga, MA; Barcena, J; Cruz Lachén, M; Gómez, JC; Hurtado, P; Lezcano, E; Pérez Bas, M; Rouco, I; Velasco, F; Zarranz, JJ | 1 |
Diamond, A; Jankovic, J | 1 |
Baron, R; Binder, A; Binder, S; Deuschl, G; Guballa, C; Herzog, J; Ludwig, J; Remien, P; Schattschneider, J; Volkmann, J; Wasner, G | 1 |
Kaufmann, H | 1 |
Gross, G; Krause, KH; Nagel-Hiemke, M | 1 |
Birkmayer, W; Danielczyk, W; Riederer, P | 1 |
Cartlidge, NE; Gibson, GJ; Gilmartin, JJ; Wright, AJ | 1 |
Tippett, GO | 1 |
Bannister, R; Forsling, M; Lightman, SL; Puritz, R; Wilcox, CS | 1 |
Idiáquez, J | 1 |
Golbe, LI; Goodman, JC; Jankovic, J; Rajput, AH | 1 |
Brin, MF; Dwork, AJ; Fahn, S; Goetz, CG; Rajput, AH; Weiner, WJ | 1 |
Ho, HH; Kwan, SY; Shan, DE; Su, MS | 1 |
Cannon, RO; Eisenhofer, G; Goldstein, DS; Holmes, C; Kopin, IJ | 1 |
Myllylä, VV; Sotaniemi, K; Suominen, K; Tolonen, U; Turkka, J | 1 |
Andersen, EB; Boesen, F | 1 |
Kimber, JR; Mathias, CJ; Watson, L | 1 |
Kuhn, W; Müller, T | 1 |
Coyle, J; Hobson, P; Meara, J | 1 |
Heinonen, E; Myllylä, V | 1 |
Kihara, M; Matsui, TA; Nishikawa, S; Saigo, K; Takahashi, M | 1 |
Albanese, A; Ben-Shlomo, Y; Fowler, C; Gilman, S; Kaufmann, H; Klockgether, T; Lang, A; Lantos, P; Litvan, I; Low, P; Mathias, C; Oliver, E; Quinn, N; Robertson, D; Schatz, I; Wenning, G | 1 |
Albanese, A; Ben-Shlomo, Y; Fowler, CJ; Gilman, S; Kaufmann, H; Klockgether, T; Lang, AE; Lantos, PL; Litvan, I; Low, PA; Mathias, CJ; Oliver, E; Quinn, N; Robertson, D; Schatz, I; Wenning, GK | 1 |
Aneman, A; Coppack, SW; Eisenhofer, G; Goldstein, DS; Holmes, C; Lamensdorf, I; Miles, JM; Swoboda, KJ | 1 |
Kanazawa, I; Momose, Y; Murata, M | 1 |
Inoue, K; Mochio, S; Oka, H | 1 |
Aktan, S; Bekiroglu, N; Gunal, DI; Nurichalichi, K; Tuncer, N | 1 |
Mathias, CJ | 1 |
Masson, C | 1 |
Belichenko, PV; Orlova, EI; Tsaĭner, B | 1 |
Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P | 1 |
Caraceni, T | 1 |
Cunningham, MA; Darby, DG; Donnan, GA | 1 |
Camerlingo, M; Casto, L; Cesana, BM; Ferraro, B; Gazzaniga, GC; Mamoli, A | 1 |
Gubskiĭ, LV | 1 |
Gleĭzer, MA; Karlov, VA | 1 |
Goetz, CG; Lutge, W; Tanner, CM | 1 |
Rae-Grant, A; Spence, JD; Young, GB | 1 |
14 review(s) available for levodopa and ANS (Autonomic Nervous System) Diseases
Article | Year |
---|---|
[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease].
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Drug Tolerance; Drugs, Chinese Herbal; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease; Phytotherapy | 2013 |
Treatment of early Parkinson's disease. Part 2.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors | 2009 |
[Dopaminergic stimulation in the non-motor symptoms of Parkinson's disease].
Topics: Autonomic Nervous System Diseases; Digestive System Diseases; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Levodopa; Mental Disorders; Parkinson Disease; REM Sleep Parasomnias; Sexual Dysfunction, Physiological; Sleep Apnea Syndromes; Urologic Diseases | 2010 |
[Non-motor fluctuations in Parkinson's disease].
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Humans; Levodopa; Mental Disorders; Motor Activity; Parkinson Disease; Somatosensory Disorders | 2010 |
[Various kinds of antiparkinson agents and their characteristics].
Topics: Animals; Antiparkinson Agents; Autonomic Nervous System Diseases; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Dopamine Agonists; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors | 2003 |
[Treatment of dementia with Lewy bodies].
Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy | 2006 |
Treatment of advanced Parkinson's disease.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition Disorders; Humans; Levodopa; Mental Disorders; Parkinson Disease; Sleep Wake Disorders | 2006 |
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States | 2008 |
[Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Motor Skills; Neurologic Examination; Neuroprotective Agents; Parkinson Disease | 1997 |
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cerebellar Diseases; Clinical Laboratory Techniques; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Pyramidal Tracts; Urinary Tract Physiological Phenomena | 1998 |
Consensus statement on the diagnosis of multiple system atrophy.
Topics: Autonomic Nervous System Diseases; Cerebellar Ataxia; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Urination Disorders | 1999 |
[Treatment of advanced Parkinson's disease].
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Severity of Illness Index | 2000 |
Neurodegeneration, parkinsonian syndromes and autonomic failure.
Topics: Autonomic Nervous System Diseases; Brain; Cardiovascular Physiological Phenomena; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders; Shy-Drager Syndrome; Sympathetic Nervous System | 2002 |
[Dysautonomia and multi-systemic atrophy of the nervous system (Shy-Drager's syndrome)].
Topics: Aged; Anus Diseases; Autonomic Nervous System Diseases; Eye Diseases; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Shy-Drager Syndrome; Time Factors; Urinary Bladder Diseases; Vasoconstrictor Agents | 1992 |
5 trial(s) available for levodopa and ANS (Autonomic Nervous System) Diseases
Article | Year |
---|---|
Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
Topics: Aged; Autonomic Nervous System Diseases; Baroreflex; Blood Pressure; Catecholamines; Female; Heart Function Tests; Heart Rate; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Supine Position; Time | 2004 |
Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; Chi-Square Distribution; Combined Modality Therapy; Disability Evaluation; Electric Stimulation Therapy; Female; Follow-Up Studies; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome | 2005 |
Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Physiological Phenomena; Deep Brain Stimulation; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome; Vasoconstriction | 2007 |
Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease.
Topics: Analysis of Variance; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Diseases; Electrocardiography; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Prospective Studies; Reflex; Selegiline; Tilt-Table Test | 1997 |
Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction.
Topics: Adult; Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Autonomic Nervous System Diseases; Blood Pressure; Enzyme Inhibitors; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Reflex; Sympathetic Nervous System; Vasoconstriction | 1997 |
44 other study(ies) available for levodopa and ANS (Autonomic Nervous System) Diseases
Article | Year |
---|---|
Marked response to levodopa in a patient with multiple system atrophy presenting with orthostatic hypotension: should reduced DAT uptake on DaTSCAN be a criterion for response to levodopa?
Topics: Autonomic Nervous System Diseases; Blood Pressure; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy | 2022 |
[Motor and autonomic disorders influence on pain syndrome of patients with Parkinson's disease of the I-III H&Y stages].
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Quality of Life | 2023 |
"New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction".
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Female; Galvanic Skin Response; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sweating | 2019 |
Association between autonomic dysfunction and fatigue in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Surveys and Questionnaires; Tetrabenazine | 2017 |
Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Electrophysiology; Female; Galvanic Skin Response; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2019 |
Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Female; Gastrointestinal Diseases; Ghrelin; Hormones; Humans; Levodopa; Male; Multiple System Atrophy | 2013 |
Dry mouth: an overlooked autonomic symptom of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Autonomic Nervous System Diseases; Female; Humans; Levodopa; Male; Middle Aged; Mouth Diseases; Parkinson Disease; Prevalence; Sialorrhea; Surveys and Questionnaires | 2011 |
The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
Topics: Analgesics, Opioid; Animals; Autonomic Nervous System Diseases; Benzylamines; Biguanides; Brain Chemistry; Cerebellum; Dopamine; Hippocampus; Levodopa; Ligands; Male; Morphine; Neurotoxins; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2015 |
Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
Topics: Age Factors; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Autonomic Pathways; Diabetes Complications; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Neural Conduction; Neuromuscular Junction; Parkinson Disease; Parkinsonian Disorders; Peripheral Nervous System Diseases; Skin | 2016 |
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Brain; Fatal Outcome; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive; Synucleins; tau Proteins | 2009 |
[Autonomic disorders in Parkinson's disease].
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Causality; Comorbidity; Constipation; Deglutition Disorders; Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Incidence; Levodopa; Male; Middle Aged; Nocturia; Parkinson Disease; Severity of Illness Index; Sex Distribution; Sialorrhea; Statistics, Nonparametric; Urinary Incontinence; Urologic Diseases; Vomiting | 2011 |
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cohort Studies; Color Perception; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Polysomnography; Psychomotor Performance; REM Sleep Behavior Disorder; Smell; Socioeconomic Factors | 2012 |
The spectrum of nonmotor symptoms in early Parkinson disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Parkinson Disease; Surveys and Questionnaires | 2013 |
Parkin disease: a phenotypic study of a large case series.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dystonia; Female; Genetic Predisposition to Disease; Humans; Levodopa; Ligases; Male; Mental Disorders; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; Polymerase Chain Reaction; Ubiquitin-Protein Ligases | 2003 |
Association between supine hypertension and orthostatic hypotension in autonomic failure.
Topics: Aged; Autonomic Nervous System Diseases; Baroreflex; Blood Pressure; Female; Fludrocortisone; Heart; Humans; Hypertension; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Retrospective Studies; Supine Position; Sympathetic Nervous System; Vagus Nerve; Valsalva Maneuver | 2003 |
Heart rate variability and Parkinson's disease severity.
Topics: Autonomic Nervous System Diseases; Cardiovascular System; Chronobiology Disorders; Disease Progression; Female; Heart Rate; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Surveys and Questionnaires; Sympathetic Nervous System; Up-Regulation; Vagus Nerve | 2003 |
[Diagnosis and therapy for patients with Parkinson's disease (discussion)].
Topics: Autonomic Nervous System Diseases; Disease Progression; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Life Style; Low Back Pain; Mental Disorders; Neurosurgical Procedures; Parkinson Disease; Stereotaxic Techniques | 2003 |
[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
Topics: Aged; Antiparkinson Agents; Apomorphine; Autonomic Nervous System; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease | 2006 |
Plasma catecholamines during activation of the sympathetic nervous system in a patient with Shy-Drager syndrome.
Topics: Autonomic Nervous System Diseases; Benserazide; Catecholamines; Dopamine; Epinephrine; Female; Humans; Levodopa; Middle Aged; Norepinephrine; Physical Exertion; Posture; Shy-Drager Syndrome; Sympathetic Nervous System | 1980 |
Symptoms and side effects in the course of Parkinson's disease.
Topics: Autonomic Nervous System Diseases; Dementia; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine | 1983 |
Upper airway obstruction complicating the Shy-Drager syndrome.
Topics: Adult; Airway Obstruction; Autonomic Nervous System Diseases; Benserazide; Double-Blind Method; Humans; Levodopa; Male; Shy-Drager Syndrome; Tidal Volume | 1984 |
Levodopa: long-term impact on Parkinson's disease.
Topics: Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Parkinson Disease; Shy-Drager Syndrome | 1981 |
Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone.
Topics: Aged; Arginine Vasopressin; Autonomic Nervous System Diseases; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Naloxone; Physical Stimulation; Posture | 1983 |
[Idiopathic orthostatic hypotension (Shy Drager's syndrome) (author's transl)].
Topics: Autonomic Nervous System Diseases; Female; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Shy-Drager Syndrome | 1980 |
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.
Topics: Atrophy; Autonomic Nervous System Diseases; Brain; Carbon Monoxide Poisoning; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Levodopa; Middle Aged; Neurologic Examination; Ophthalmoplegia; Parkinson Disease | 1993 |
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Brain; Diagnosis, Differential; Erectile Dysfunction; Humans; Levodopa; Male; Middle Aged; Multiple Myeloma; Neurologic Examination; Paraneoplastic Syndromes; Parkinson Disease; Urinary Incontinence; Verbal Behavior | 1996 |
Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy.
Topics: Abdominal Muscles; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Biperiden; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Electromyography; Humans; Levodopa; Male; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease | 1996 |
Sympathetic cardioneuropathy in dysautonomias.
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart; Humans; Levodopa; Middle Aged; Myocardium; Norepinephrine; Parasympathetic Nervous System; Parkinson Disease; Reference Values; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed | 1997 |
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
Topics: Adrenergic alpha-Agonists; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, Differential; Dopamine; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Middle Aged; Norepinephrine; Parkinson Disease | 1997 |
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular System; Drug Therapy, Combination; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Valsalva Maneuver | 1998 |
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular System; Drug Therapy, Combination; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Valsalva Maneuver | 1998 |
Problem in prolonged levodopa administration of Parkinson disease patients--from the standpoint of the autonomic nervous function.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Autonomic Nervous System Diseases; Dopamine Agents; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Time Factors | 1998 |
Sources and physiological significance of plasma dopamine sulfate.
Topics: Adult; Aromatic-L-Amino-Acid Decarboxylases; Arteries; Autonomic Nervous System Diseases; Blotting, Western; Dopamine; Dopamine Agents; Fasting; Female; Food; Gastrointestinal Neoplasms; Humans; Levodopa; Male; Nitroprusside; Portal Vein; Trimethaphan | 1999 |
[Relation between autonomic dysfunction and progression of Parkinson's disease].
Topics: Adult; Aged; Autonomic Nervous System Diseases; Baroreflex; Disease Progression; Humans; Levodopa; Middle Aged; Parkinson Disease; Valsalva Maneuver | 2001 |
The clinical profile of nonmotor fluctuations in Parkinson's disease patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dopamine Agents; Humans; Levodopa; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease; Sensation Disorders; Surveys and Questionnaires; Time Factors | 2002 |
[Biochemical aspects of the pathogenesis of autonomic and emotional disorders in functional disorders of the dopamine system].
Topics: Animals; Autonomic Nervous System Diseases; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine; Hypothalamus; Levodopa; Male; Mood Disorders; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Synaptosomes | 1991 |
Autonomic involvement in extrapyramidal and cerebellar disorders.
Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver | 1991 |
The diagnosis of multiple system atrophy.
Topics: Atrophy; Autonomic Nervous System Diseases; Cerebellar Diseases; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity | 1991 |
Controlled-release delivery of L-dopa associated with nonfatal hyperthermia, rigidity, and autonomic dysfunction.
Topics: Adult; Autonomic Nervous System Diseases; Benserazide; Delayed-Action Preparations; Drug Combinations; Fever; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease | 1991 |
Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients.
Topics: Aged; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular System; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex | 1990 |
[Diagnosis and treatment of Shy-Drager syndrome].
Topics: Autonomic Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ephedrine; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Mineralocorticoids; Movement Disorders; Shy-Drager Syndrome | 1989 |
[Autonomic dysfunction in patients with temporal lobe epilepsy].
Topics: Adolescent; Adrenal Glands; Adult; Autonomic Nervous System; Autonomic Nervous System Diseases; Catecholamines; Epilepsy, Temporal Lobe; Epinephrine; Heart Rate; Humans; Insulin; Levodopa; Middle Aged; Sympathetic Nervous System | 1988 |
Autonomic dysfunction in Parkinson's disease.
Topics: Adult; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Body Temperature; Extremities; Female; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sweating; Valsalva Maneuver | 1986 |
Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
Topics: Autonomic Nervous System Diseases; Carbidopa; Drug Combinations; Female; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Monoamine Oxidase Inhibitors; Shy-Drager Syndrome | 1985 |